70 activities found

Best of the Day: Great Debates & Updates in Hematologic Malignancies 2015: Lymphoma

The Best of the Day educational activity recorded during Great Debates & Updates in Hematologic Malignancies held April 17-18. 2015 in New York, NY is a conversation overview between Dr. Jim Epstein and Dr. John Leonard covering the most clinically pertinent data presented during the lymphoma session of the Congress. Topics discussed during this conversation include selection of therapy for patients with follicular lymphoma, mantle cell lymphoma, and double hit lymphoma as well as standard of care and novel therapies that have the potential to impact clinical outcomes and patient quality of life.
0.5 CME

Best of the Day: Great Debates & Updates in Hematologic Malignancies 2015: Multiple Myeloma

This Best of the Day activity features a videotaped conversation between Dr. Jim Epstein and Dr. Ruben Niesvizky highlighting the key points presented for management of patients with multiple myeloma during Great Debates & Updates in Hematologic Malignancies held April 17-18. 2015 in New York, NY. This expert review includes discussion of management options for newly diagnosed patients eligible for transplant, newly diagnosed patients ineligible for transplant, and relapsed/refractory patients.
0.5 CME

Best of the Day: Great Debates & Updates in Hematologic Malignancies 2015: Leukemia, MPN, MDS

This Best of the Day activity features a videotaped conversation between Dr. Jim Epstein and Dr. David Steensma highlighting the key points presented for management of patients with leukemia or myelodysplastic syndromes during Great Debates & Updates in Hematologic Malignancies held April 17-18. 2015 in New York, NY. This expert review includes discussion of therapeutic options for the treatment of patients with CML and MDS.
0.5 CME

Podium to Practice: Cornerstones Health and The UAMS College of Medicine Presents: Best of Digestive Diseases Week in Inflammatory Bowel Disease 2015

Cornerstones Health is pleased to present this Best of Digestive Diseases Week in Inflammatory Bowel Disease 2015: Podium to Practice™ program. In these educational webisodes, a faculty of national and international experts share the most practical and important updates fresh from the podium which will immediately influence your care of patients with Inflammatory Bowel Disease (IBD) and provide a sustained impact on patient outcomes.
1 CME

Interactive Case: Clinical Case Challenge: Multiple Myeloma

Significant progress has been made in uncovering molecular and cellular pathophysiology, examining the clinical spectrum of disease, and defining and refining effective treatment approaches for multiple myeloma (MM). While several therapeutic agents are safe and effective MM, challenges remain in establishing the most effective approaches for optimizing consolidation and maintenance strategies. To address these challenges, this activity is a case-based exploration of evidence-based practices for managing MM.
0.75 CME

Expert Perspectives: Great Debates & Updates in Inflammatory Bowel Diseases 2015: Pediatric Session

Filmed at the 2015 Great Debates and Updates in Inflammatory Bowel Disease (IBD) meeting held March 27-28, 2015 in San Francisco, CA. This online activity includes a video discussion between Marla C. Dubinsky, MD and Joel R. Rosh, MD focused on pediatric IBD. This engaging conversational format provides expert perspectives on current issues in choosing and incorporating therapeutic management into practice and strategies to optimize clinical outcomes of various treatment options in pediatric patients with IBD.
0.5 CME

Expert Perspectives: Great Debates & Updates in Inflammatory Bowel Diseases 2015: Clinical Session

Filmed at the 2015 Great Debates and Updates in Inflammatory Bowel Disease (IBD) meeting, March 27-28, 2015 in San Francisco, CA. This online activity includes a video discussion between Marla C. Dubinsky, MD and Joel R. Rosh, MD focused on adult IBD. This engaging conversational format provides expert perspectives on current issues in choosing and incorporating therapeutic management into practice and strategies to optimize clinical outcomes of various treatment options.
0.5 CME

Best of the Day: from the 21st Annual NOCR Meeting: Updates in Clinical Oncology: Day 1

Oncology is an area of medicine where there is rapid evolution of therapeutic options and practice guidelines, changing the way patients with cancer are treated on a continual basis. Every year a substantial amount of seminal data and potential practice-changing clinical results in oncology are presented at large national and international medical society meetings. This activity highlights aspects of the 21st Annual NOCR Meeting: Updates in Clinical Oncology in order to provide expert guidance to community-based oncology specialists on the most significant advances in screening, prevention, and management of diverse types of solid tumors, and to enable them to evaluate and interpret the potential clinical utility of emerging treatment options for enhancing patient care. Topics of discussion include the following: breast cancer, melanoma, and gastrointestinal malignancies.
1.25 CME

Best of the Day: from the 21st Annual NOCR Meeting: Updates in Clinical Oncology: Day 2

Oncology is an area of medicine where there is rapid evolution of therapeutic options and practice guidelines, changing the way patients with cancer are treated on a continual basis. Every year a substantial amount of seminal data and potential practice-changing clinical results in oncology are presented at large national and international medical society meetings. This activity highlights aspects of the 21st Annual NOCR Meeting: Updates in Clinical Oncology in order to provide expert guidance to community-based oncology specialists on the most significant advances in screening, prevention, and management of diverse types of solid tumors, and to enable them to evaluate and interpret the potential clinical utility of emerging treatment options for enhancing patient care. Topics of discussion include the following: genitourinary, gynecologic, and thoracic malignancies.
1.25 CME

Webcast: Late Stage Investigational Proteasome Inhibitors and Their Potential Impact on Clinical Outcomes

Dr. Meletios Dimopoulos discusses “Late-stage investigational proteasome inhibitors and their potential impact on clinical outcomes” during the satellite symposium Enhancing Clinical Outcomes in Relapsed/Refractory Multiple Myeloma at the 11th European Congress on Hematologic Malignancies: From Clinical Science to Clinical Practice. This activity provides review and analysis of pertinent clinical trial data highlighting clinical considerations for the use of second generation proteasome inhibitors and their impact on outcomes in patients with relapsed/refractory multiple myeloma.